Evidence map›Paper›PMID 25156554›Full record

ArticleBreast cancer research : BCR2014

P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.

Hana Jin, So Young Eun, Jong Sil Lee, Sang Won Park, Jae Heun Lee, Ki Churl Chang, Hye Jung Kim

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 90 citations in OpenAlex.

  1. Review
  2. P2YInternational journal of molecular sciences · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. ATP purinergic receptor signalling promotes Sca-1Cell communication and signaling : CCS · 2023
    Article
  9. Article
  10. Therapeutic potential for P2YPurinergic signalling · 2023
    Review
  11. Article
  12. The P2 purinoceptors in prostate cancer.Purinergic signalling · 2023
    Review
  13. The ATP-dependent Pathways and Human Diseases.Current medicinal chemistry · 2023
    Article
  14. Amplified CaInternational journal of cancer · 2022
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hana JinDepartment of Pharmacology, School of Medicine, Institute of Health Sciences, Gyeongsang National University, Jinju, Korea. hahaha-_-0001@hamail.net.
So Young EunDepartment of Pharmacology, School of Medicine, Institute of Health Sciences, Gyeongsang National University, Jinju, Korea. eunsoyg@hanmail.net.
Jong Sil LeeDepartment of Pathology, School of Medicine, Institute of Health Sciences, Gyeongsang National University, Jinju, 660-751, Korea. jongsil25@dreamwiz.com.
Sang Won ParkDepartment of Pharmacology, School of Medicine, Institute of Health Sciences, Gyeongsang National University, Jinju, Korea. parksw@gnu.ac.kr.
Jae Heun LeeDepartment of Pharmacology, School of Medicine, Institute of Health Sciences, Gyeongsang National University, Jinju, Korea. jhlee@gnu.ac.kr.
Ki Churl ChangDepartment of Pharmacology, School of Medicine, Institute of Health Sciences, Gyeongsang National University, Jinju, Korea. kcchang@gnu.ac.kr.
Hye Jung KimDepartment of Pharmacology, School of Medicine, Institute of Health Sciences, Gyeongsang National University, Jinju, Korea. hyejungkim@gnu.ac.kr.
Gyeongsang National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionExtracellular nucleotides are released and detectable in a high concentration within the tumor microenvironment. G protein-coupled P2Y2 nucleotide receptor (P2Y2R) is activated equipotently by adenosine triphosphate (ATP) and uridine 5'-triphosphate (UTP), which mediate proinflammatory responses such as cell migration and proliferation. However, the role of P2Y2R in the process of cancer metastasis remains unclear. This study aimed to determine the role of P2Y2R in the proliferation, migration and invasion of highly metastatic MDA-MB-231 breast cancer cells through crosstalk with endothelial cells (ECs).

methodsATP release and P2Y2R activity between high metastatic breast cancer cell MDA-MB-231 and low metastatic breast cancer cell MCF-7 were compared. Then, the role of P2Y2R on tumor growth and invasion via crosstalk with ECs was examined in vitro, using MDA-MB-231 cells and ECs transfected with control- or P2Y2R-siRNA, and in vivo, using an animal model injected with control-shRNA- or P2Y2R-shRNA-transfected MDA-MB-231 cells.

resultsWe found that this highly metastatic breast cancer cell line released higher levels of ATP and showed a higher P2Y2R activity in comparison to a low metastatic breast cancer cell line, MCF-7. In MDA-MB-231 cells, P2Y2R activation by ATP or UTP increased proliferation at 24 or 72 hours, which was abolished by P2Y2R knock-down. In addition, the adhesion of MDA-MB-231 cells to ECs and cell migration were both significantly increased by ATP or UTP through the expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in MDA-MB-231 or ECs but not in cells where P2Y2R was knocked down. Furthermore, ATP- or UTP-mediated activation of P2Y2R induced MDA-MB-231 invasion through ECs, increased matrix metalloproteinase-9 (MMP-9) activity and vascular endothelial growth factor (VEGF) production in MDA-MB-231 and induced the phosphorylation of vascular endothelial (VE)-cadherin in ECs. Tumor growth and metastasis to other tissues were dramatically reduced, and body weight was increased in mice injected with P2Y2R-shRNA-transfected MDA-MB-231 cells compared to mice injected with control shRNA-transfected MDA-MB-231 cells.

conclusionThis study suggests that P2Y2R may play an important role in cancer metastasis via modulation of the crosstalk between cancer cells and ECs.

Indexed as

Adenosine TriphosphateAnimalsAntigens, CDBreast NeoplasmsCadherin 5CadherinsCell CommunicationCell MovementCell ProliferationEndothelial CellsFemaleHumansLung NeoplasmsMatrix Metalloproteinase 9MCF-7 CellsMice, NudeAdenosine TriphosphateAntigens, CDCadherin 5CadherinsMatrix Metalloproteinase 9MMP9 protein, humanReceptors, Purinergic P2Y2Uridine TriphosphateVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID25156554
PMCPMC4406012
OpenAlexW2135447488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.